TY - JOUR
T1 - Non-Hodgkin's lymphoma
T2 - Clinical practice guidelines in oncology™
AU - Zelenetz, Andrew D.
AU - Advani, Ranjana H.
AU - Buadi, Francis
AU - Cabanillas, Fernando
AU - Caligiuri, Michael A.
AU - Czuczman, Myron S.
AU - Damon, Lloyd E.
AU - Fayad, Luis
AU - Flinn, Ian W.
AU - Forero, Andres
AU - Glenn, Martha J.
AU - Gockerman, Jon P.
AU - Gordon, Leo I.
AU - Harris, Nancy Lee
AU - Hoppe, Richard T.
AU - Kaminski, Mark S.
AU - LaCasce, Ann S.
AU - Nademanee, Auyporn
AU - Porcu, Pierluigi
AU - Press, Oliver
AU - Prosnitz, Leonard
AU - Smith, Mitchell R.
AU - Sotomayor, Eduardo M.
AU - Vose, Julie M.
AU - Yahalom, Joachim
PY - 2006/3
Y1 - 2006/3
N2 - Non-Hodgkin's lymphomas (NHLs) may be classified on the basis of morphology, natural history, and immunophenotypic and molecular characteristics. These guidelines were developed for more common NHL histologic types, including chronic lymphocytic leukemia/small lymphocytic lymphoma, follicular lymphoma, and diffuse large B-cell lymphoma, and for less common entities with unique natural histories and therapies, such as marginal zone lymphoma, mantle cell lymphoma, and highly aggressive lymphoma subtypes, including Burkitt's, and lymphoblastic lymphomas and AIDS-related B-cell lymphomas. Certain components of the diagnosis and therapy of the various NHLs are similar. In all cases, an accurate pathologic diagnosis must first be made.
AB - Non-Hodgkin's lymphomas (NHLs) may be classified on the basis of morphology, natural history, and immunophenotypic and molecular characteristics. These guidelines were developed for more common NHL histologic types, including chronic lymphocytic leukemia/small lymphocytic lymphoma, follicular lymphoma, and diffuse large B-cell lymphoma, and for less common entities with unique natural histories and therapies, such as marginal zone lymphoma, mantle cell lymphoma, and highly aggressive lymphoma subtypes, including Burkitt's, and lymphoblastic lymphomas and AIDS-related B-cell lymphomas. Certain components of the diagnosis and therapy of the various NHLs are similar. In all cases, an accurate pathologic diagnosis must first be made.
KW - Chronic lymphocytic leukemia
KW - Follicular lymphoma
KW - Mantle cell lymphoma
KW - Marginal zone lymphoma
KW - NCCN Clinical Practice Guidelines
KW - Non-Hodgkin's lymphoma
KW - Small lymphocytic lymphoma
UR - http://www.scopus.com/inward/record.url?scp=33645909890&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33645909890&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2006.0025
DO - 10.6004/jnccn.2006.0025
M3 - Review article
C2 - 16507273
AN - SCOPUS:33645909890
SN - 1540-1405
VL - 4
SP - 258
EP - 310
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 3
ER -